News
ONCO
1.105
-40.27%
-0.745
Onconetix Stock Plunges On Realbotix Acquisition
NASDAQ · 3h ago
BRIEF-Realbotix Corp. Announces The Sale Of Realbotix, Llc Subsidiary To A Nasdaq Listed Issuer
Reuters · 3h ago
Realbotix announces the sale of subsidiary to Onconetix
Seeking Alpha · 4h ago
Onconetix to acquire Realbotix LLC in all-stock transaction
TipRanks · 5h ago
Onconetix to Acquire Realbotix, Pivot to Humanoid AI
TipRanks · 5h ago
ONCO to Acquire Realbotix Subsidiary in All-Stock Deal
Reuters · 5h ago
Onconetix Acquires Realbotix in All-Stock Deal
Reuters · 5h ago
*Onconetix: Will Acquire 100% of the Issued and Outstanding Equity Interests of Realbotix in an all-Stk Transaction >ONCO
Dow Jones · 5h ago
ONCONETIX INC - IMMEDIATELY UPON CLOSING OF DEAL, REALBOTIX PARENT WILL OWN BETWEEN 75% AND 90% OF FULLY DILUTED COMMON SHARES OF COMBINED COMPANY
Reuters · 5h ago
ONCONETIX INC - ANDREW KIGUEL WILL BECOME CEO OF COMBINED COMPANY FOLLOWING CLOSING
Reuters · 5h ago
ONCONETIX INC - ANDREW KIGUEL TO BECOME CEO OF COMBINED COMPANY
Reuters · 5h ago
REALBOTIX CORP - ONCONETIX TO BUY 100% OF REALBOTIX, LLC IN ALL-STOCK DEAL
Reuters · 5h ago
*Onconetix To Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company >ONCO
Dow Jones · 5h ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 6h ago
Onconetix Shareholders Approve Flexible Reverse Stock Split Plan
TipRanks · 2d ago
Onconetix Inc. hielt Sonderversammlung ab
Reuters · 2d ago
Onconetix Inc. Held Special Shareholder Meeting
Reuters · 2d ago
Weekly Report: what happened at ONCO last week (0202-0206)?
Weekly Report · 3d ago
Weekly Report: what happened at ONCO last week (0126-0130)?
Weekly Report · 02/02 10:15
Weekly Report: what happened at ONCO last week (0119-0123)?
Weekly Report · 01/26 10:15
More
Webull provides a variety of real-time ONCO stock news. You can receive the latest news about Onconetix through multiple platforms. This information may help you make smarter investment decisions.
About ONCO
Onconetix, Inc. is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men’s health and oncology. The Company owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.